What Nimvastid contains
- The active substance is rivastigmine hydrogen tartrate. Each Nimvastid 1.5 mg capsule contains 1.5 mg of rivastigmine as rivastigmine hydrogen tartrate. Each Nimvastid 3 mg capsule contains 3 mg of rivastigmine as rivastigmine hydrogen tartrate. Each Nimvastid 4.5 mg capsule contains 4.5 mg of rivastigmine as rivastigmine hydrogen tartrate. Each Nimvastid 6 mg capsule contains 6 mg of rivastigmine as rivastigmine hydrogen tartrate.
- The other ingredients for Nimvastid 1.5 mg capsules are microcrystalline cellulose, hypromellose, colloidal anhydrous silica, magnesium stearate in the capsule content, and titanium dioxide (E171), yellow iron oxide (E172) and gelatine in the capsule shell.
- The other ingredients for Nimvastid 3 mg, 4.5 mg and 6 mg capsules are microcrystalline cellulose, hypromellose, colloidal anhydrous silica, magnesium stearate in the capsule content, and titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172) and gelatine in the capsule shell.
What Nimvastid looks like and contents of the pack
Nimvastid 1.5 mg hard capsules, which contain a white to almost white powder, have a yellow cap and yellow body.
Nimvastid 3 mg hard capsules, which contain a white to almost white powder, have an orange cap and orange body.
Nimvastid 4.5 mg hard capsules, which contain a white to almost white powder, have a brownish red cap and brownish red body.
Nimvastid 6 mg hard capsules, which contain a white to almost white powder, have a brownish red cap and orange body.
Blister pack (PVC/PVDC/Al-foil): boxes of 14 (only for 1.5 mg), 28, 30, 56, 60 or 112 hard capsules are available.
HDPE container: boxes of 200 or 250 hard capsules are available.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
KRKA, d.d., Novo mesto, ?marje?ka cesta 6, 8501 Novo mesto, Slovenia
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:
BelgiรซBelgiqueBelgien KRKA, d.d., Novo mesto TรฉlTel 32 03 321 63 52 LuxembourgLuxemburg KRKA, d.d., Novo mesto TรฉlTel 32 03 321 63 52
KRKA Te. 359 02 962 34 50 Magyarorszรกg KRKA Magyarorszรกg Kereskedelmi Kft. Tel. 361 0 355 8490
eskรก republika KRKA R, s.r.o. Tel 420 0 221 115 150 Malta KRKA Pharma Dublin, Ltd. Tel 46 8 643 67 66
Danmark KRKA Sverige AB Tlf 46 08 643 67 66 SE Nederland KRKA, d.d., Novo mesto Tel 32 3 321 63 52 BE
Deutschland TAD Pharma GmbH Tel 49 0 4721 6060 Norge KRKA Sverige AB Tlf 46 08 643 67 66 SE
Eesti KRKA, d.d., Novo mesto Eesti filiaal Tel 372 06 597 365 รsterreich TAD Pharma GmbH Tel 49 0 4721 6060
KRKA, d.d., Novo mesto 30 0210 9581143 Polska KRKA Polska Sp.z.o.o Tel. 48 022 573 7500
Espaรฑa KRKA, d.d., Novo mesto Tel 34 061 5089 809 Portugal KRKA Farmacรชutica, Unipessoal Lda. Tel 351 021 46 43 650
France KRKA, d.d., Novo mesto Tรฉl 32 3 321 63 52 BE Ireland KRKA Pharma Dublin, Ltd. Tel 46 8 643 67 66 Romรขnia KRKA, d.d., Novo mesto Reprezentana pentru Romรขnia Tel 402 01 310 66 05 Slovenija KRKA, d.d., Novo mesto Tel 386 0 1 47 51 100
รsland KRKA Sverige AB Sรญmi 46 08 643 67 66 SE Slovenskรก republika KRKA Slovensko, s.r.o., Tel 421 0 2 571 04 501
Italia KRKA, d.d., Novo mesto Tel 39 069448827 SuomiFinland KRKA Sverige AB PuhTel 46 08 643 67 66 SE
KRKA, d.d., Novo mesto 30 0210 9581143 EL Sverige KRKA Sverige AB Tel 46 08 643 67 66 SE
Latvija KRKA, d.d., Novo mesto Tel 371 0733 8610 United Kingdom KRKA Pharma Dublin, Ltd. Tel 46 8 643 67 66
Lietuva
KRKA, d.d., Novo mestoTel: + 370 5 236 27 40
This leaflet was last approved in